Literature DB >> 16516498

In vivo imaging with cellular resolution of bone marrow cells transplanted into the ischemic brain of a mouse.

Alexy Tran-Dinh1, Alexy Tran Dinh, Nathalie Kubis, Yutaka Tomita, Bartosz Karaszewski, Yolande Calando, Karim Oudina, Hervé Petite, Jacques Seylaz, Elisabeth Pinard.   

Abstract

The aim of the study was to monitor in vivo and noninvasively the fate of single bone marrow cells (BMCs) transplanted into the ischemic brain of unirradiated mice. In vivo imaging was performed through a closed cranial window, throughout the 2 weeks following cell transplantation, using laser-scanning confocal fluorescence microscopy. The window was chronically implanted above the left parieto-occipital cortex in C57BL/6J adult mice. BMC (3 x 10(5) nucleated cells in 0.5 microL medium) from 5-week-old transgenic mice, ubiquitously expressing green fluorescent protein (GFP), was transplanted into the ipsilateral cortex 24 h after the induction of focal ischemia by coagulation of the left middle cerebral artery (n = 15). Three nonischemic mice served as controls. Repeated in vivo imaging, up to a depth of 200 microm, revealed that BMCs survived within the ischemic and peri-ischemic cortex, migrated significantly towards the lesion, proliferated and adopted a microglia-like morphology over 2 weeks. These results were confirmed using ex vivo imaging after appropriate immunocytochemical treatments. This study indicates that confocal fluorescence microscopy is a reliable and unique tool to repeatedly assess with cellular resolution the in vivo dynamic fate of fluorescent cells transplanted into a mouse brain. These results also provide the first in vivo findings on the fate of single BMCs transplanted into the ischemic brain of unirradiated mice.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16516498     DOI: 10.1016/j.neuroimage.2006.01.019

Source DB:  PubMed          Journal:  Neuroimage        ISSN: 1053-8119            Impact factor:   6.556


  4 in total

1.  Dual-modality monitoring of targeted intraarterial delivery of mesenchymal stem cells after transient ischemia.

Authors:  Piotr Walczak; Jian Zhang; Assaf A Gilad; Dorota A Kedziorek; Jesus Ruiz-Cabello; Randell G Young; Mark F Pittenger; Peter C M van Zijl; Judy Huang; Jeff W M Bulte
Journal:  Stroke       Date:  2008-03-06       Impact factor: 7.914

Review 2.  Cell Therapy for Ischemic Stroke: How to Turn a Promising Preclinical Research into a Successful Clinical Story.

Authors:  Gabrielle Mangin; Nathalie Kubis
Journal:  Stem Cell Rev Rep       Date:  2019-04       Impact factor: 5.739

3.  MSCs: Delivery Routes and Engraftment, Cell-Targeting Strategies, and Immune Modulation.

Authors:  Thomas J Kean; Paul Lin; Arnold I Caplan; James E Dennis
Journal:  Stem Cells Int       Date:  2013-08-13       Impact factor: 5.443

4.  Interleukin-1beta and tumor necrosis factor-alpha are expressed by different subsets of microglia and macrophages after ischemic stroke in mice.

Authors:  Bettina H Clausen; Kate L Lambertsen; Alicia A Babcock; Thomas H Holm; Frederik Dagnaes-Hansen; Bente Finsen
Journal:  J Neuroinflammation       Date:  2008-10-23       Impact factor: 8.322

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.